Department of Orthopedics, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, Zhejiang, China.
Department of Endocrinology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, 310007, China.
J Orthop Surg Res. 2022 Sep 29;17(1):433. doi: 10.1186/s13018-022-03323-x.
Tennis elbow has long been one of the most controversial subjects in orthopaedics. Many scholars thought the use of open or arthroscopic surgery was reserved for patients with refractory symptoms. Therapy with percutaneous acupotomy performed under local anaesthesia also removes degenerated tissue, releases strain, and therefore provides an alternative treatment option to surgical excision.
The aim of this single-blinded randomized control trial was to examine the long-term clinical effectiveness of a nonsurgical percutaneous release technique (acupotomy) and the current recommended treatment (steroid injection) in people diagnosed with a refractory tennis elbow. Ninety patients with refractory symptoms were included. The intervention period was 6 weeks. According to the classification, 38 patients had extra-articular tennis elbow, 36 patients had intraarticular tennis elbow, and 16 patients had mixed type tennis elbow. Forty-five patients were randomly assigned to treatment with percutaneous release by acupotomy according to their classified condition, and 45 patients were randomly assigned to treatment with steroid injection alone. The visual analogue scale (VAS), a tenderness assessment, a grip assessment, and the Nirschl staging system were used for outcome evaluation at pretreatment and the posttreatment timepoints from 12 to 48 weeks.
During the first weeks, there were no differences observed between the groups. By 6, 24 and 48 weeks, significant differences were observed between the two groups. The acupotomy group scored significantly better in visual analogue scale score (VAS) of pain, tenderness during palpation, pain-free grip strength (PFGS) and Nirschl staging than the corticosteroid group.
For patients with lateral epicondylitis, acupotomy is just as effective as corticosteroid injections in the short term (< 6 weeks). In the long term, acupotomy has greater efficacy and is associated with a lower rate of recurrence than corticosteroid injections in the management of lateral epicondylitis.
The National Health Commission announced the "ethical review measures for biomedical research involving people" in 2019, which was not mandatory in previous studies.
网球肘一直是矫形外科中最具争议的课题之一。许多学者认为,开放式或关节镜手术仅适用于症状难治的患者。在局部麻醉下进行经皮针刀治疗也可以切除退变组织,释放张力,因此为手术切除提供了另一种治疗选择。
本单盲随机对照试验的目的是研究非手术经皮松解技术(针刀)与目前推荐的治疗方法(皮质类固醇注射)在诊断为难治性网球肘患者中的长期临床疗效。纳入 90 例难治性症状患者。干预期为 6 周。根据分类,38 例为外网球肘,36 例为内网球肘,16 例为混合网球肘。45 例根据分类情况随机分配接受经皮针刀松解治疗,45 例随机分配接受皮质类固醇注射治疗。视觉模拟量表(VAS)、压痛评估、握力评估和 Nirschl 分期系统用于治疗前和治疗后 12-48 周的疗效评估。
在最初几周内,两组之间没有差异。在 6、24 和 48 周时,两组之间观察到显著差异。针刀组在疼痛 VAS 评分、触诊压痛、无痛握力(PFGS)和 Nirschl 分期方面的评分均显著优于皮质类固醇组。
对于外侧肱骨上髁炎患者,针刀与皮质类固醇注射在短期(<6 周)内同样有效。在长期内,针刀在治疗外侧肱骨上髁炎方面比皮质类固醇注射更有效,且复发率更低。
国家卫生健康委员会于 2019 年公布了“涉及人的生物医学研究伦理审查办法”,在此之前的研究中并非强制性的。